Chugh K
Department of Pediatrics, Sir Ganga Ram Hospital, New Rajinder Nagar, New Delhi.
Indian J Pediatr. 2001 Sep;68 Suppl 4:S42-7.
Children with asthma who are not well controlled in spite of optimum therapy outlined in Asthma Management Guidelines are said to have 'difficult-to manage asthma' or 'difficult asthma'. Several phenotypes of this subset of asthma have been described. However, before any child is labeled as difficult asthma a thorough search for an alternative diagnosis should be made. Thus, one should look for recurrent aspiration pneumonia, tuberculosis, foreign body aspiration, tracheomalacia, bronchomalacia, cystic fibrosis etc. Causes of treatment failure range from unidentified exacerbating factors, noncompliance, inappropriate inhalers and spacers and true steroid dependence or resistance. Economics of the treatment and social beliefs should also be taken into consideration at the time of finalizing the management plan. Management involves recognizing and correcting the above factors. However, steroids form the main pillar of treatment. Majority of the patients can be controlled by optimizing inhaled steroid therapy and possibly adding steroid sparing agents. Thus, long acting bata-2 agonists, long acting theophyllines and leukotriene inhibiters may be useful. A few children will require continuous oral steroid therapy and an occasional one may be actually steroid steroid resistant. Such children are best managed at asthma specialist centers where experimental drugs like, methotrexate cyclosporin or IVIG may be tried on an individual basis under close monitoring.
尽管按照哮喘管理指南进行了最佳治疗,但哮喘仍未得到有效控制的儿童被称为患有“难治性哮喘”或“重症哮喘”。已描述了这类哮喘的几种表型。然而,在将任何儿童标记为难治性哮喘之前,应全面排查是否存在其他诊断。因此,应排查反复吸入性肺炎、肺结核、异物吸入、气管软化、支气管软化、囊性纤维化等疾病。治疗失败的原因包括未识别的加重因素、不依从、吸入器和储雾罐使用不当以及真正的类固醇依赖或抵抗。在确定治疗方案时,还应考虑治疗的经济性和社会观念。治疗包括识别并纠正上述因素。然而,类固醇是治疗的主要支柱。大多数患者可通过优化吸入性类固醇治疗并可能添加类固醇节省剂来控制病情。因此,长效β2受体激动剂、长效茶碱和白三烯抑制剂可能会有用。少数儿童需要持续口服类固醇治疗,偶尔会有儿童对类固醇实际耐药。这类儿童最好在哮喘专科中心接受治疗,在密切监测下,可根据个体情况尝试使用甲氨蝶呤、环孢素或静脉注射免疫球蛋白等实验性药物。